Zak Huang
About Zak Huang
Zak Huang serves as the Vice President of Regulatory Affairs at Nimbus Therapeutics, bringing extensive experience from roles at CSL Behring and Merck & Co., among others, in the pharmaceutical and medical device sectors.
Work at Nimbus Therapeutics
Zak Huang serves as the Vice President of Regulatory Affairs at Nimbus Therapeutics, a position he has held since 2022. In this role, he focuses on navigating regulatory landscapes to support the development of innovative therapies. His expertise aids in aligning regulatory strategies with the company's business objectives, ensuring compliance while accelerating product development.
Previous Experience at CSL Behring
Prior to his current role, Zak Huang worked at CSL Behring as the Head of China R&D from 2015 to 2021. During his six years in Shanghai, he was responsible for leading research and development initiatives, contributing to the advancement of therapeutic solutions in the biopharmaceutical sector.
Regulatory Strategy at Merck & Co., Inc.
Zak Huang spent 11 years at Merck & Co., Inc. from 2004 to 2015, where he held the position of Leader in Global Regulatory Strategy. His work focused on pharmaceuticals, biologics, and combination products, allowing him to develop a comprehensive understanding of regulatory processes on a global scale.
Educational Background and Expertise
Zak Huang completed his Post-Doctoral Fellowship in Cardiovascular Clinical Research at the University of Minnesota Medical School from 1977 to 1982. He also holds an MD and a Master of Science in Sports Medicine from Nanjing Medical University. His educational background complements his extensive experience in regulatory affairs, enabling him to effectively address complex regulatory challenges.
Leadership Roles and Contributions
In addition to his regulatory roles, Zak Huang served as Vice President of the Sino-American Pharmaceutical Professionals Association (SAPA) from 2009 to 2011. His leadership in this organization reflects his commitment to fostering collaboration within the pharmaceutical community and enhancing professional development among peers.